Haisco Pharmaceutical Hits Day Low Amid Price Pressure, Reaches CNY 48.65

Haisco Pharmaceutical Group Co., Ltd. experienced a notable decline today, with the stock dropping by 3.57% on March 23, 2026. The stock reached an intraday low of CNY 48.65, reflecting a challenging trading session. In terms of performance metrics, Haisco's one-day performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.63%. Over the past week, Haisco has shown a slight increase of 0.7%, while the index has decreased by 6.65%. On a monthly basis, the stock has gained 2.61%, outperforming the index, which has declined by 6.58%. Looking at longer-term performance, Haisco has delivered a robust annual return of 34.27%, significantly higher than the index's 13.33%. However, year-to-date, the stock is down 4.11%, slightly worse than the index's decline of 3.92%. Over three years, Haisco has achieved an impressive 106.76% increase, compared to the index's 16.02%. Despite these performance indicators, the company faces challenges with a high price-to-earnings ratio of 141.00 and a return on equity of 7.32%, suggesting a complex valuation landscape.